← LEADERSHIP TERMINAL

US CONGRESS · SITTING

Christopher H. Smith

Representative for New Jersey · Republican · United States

IN THEIR OWN WORDS

It also, as we did in the original law, authorizes $100 million over 5 years to tangibly assist States' public health departments and other local entities to support the development and implementation of evidence-based research interventions and treatment with respect to the Lyme disease epidemic. I urge my colleagues to support it. Mr.

CREC-2026-07-20-PT1-PGH4640 · READ IN THE CONGRESSIONAL RECORD

I introduced my first comprehensive bill--one of many, at times we had over 100 cosponsors--called the Lyme Disease Initiative Act of 1998, almost 30 years ago. We could not move it. It was blocked over and over again.

CREC-2026-07-20-PT1-PGH4640 · READ IN THE CONGRESSIONAL RECORD

She said there is exciting research now using cord blood to treat children with cerebral palsy, birth asphyxia, and autism. Mr. Speaker, the National Cord Blood Inventory--created by the original law and continued in this reauthorization--provides funding to public cord blood banks participating in the program to allow them to expand the…

CREC-2026-07-20-PT1-PGH4642 · READ IN THE CONGRESSIONAL RECORD

Joanne Kurtzberg of Duke University, an internationally renowned expert in pediatric hematology, oncology, and umbilical cord blood banking and transplantation. Dr. Kurtzberg helped draft our original law 26 years ago. It took 5 long years to enact it into law.

CREC-2026-07-20-PT1-PGH4642 · READ IN THE CONGRESSIONAL RECORD

Mr. Speaker, I thank Chairman Guthrie for his personal and extraordinarily strong support of H.R. 4348, and his staff, director Megan Jackson, Health Subcommittee staff Jay Gulshen and Emma Schultheis.

CREC-2026-07-20-PT1-PGH4640 · READ IN THE CONGRESSIONAL RECORD

434--again as we did in the original law--authorizes cooperative agreement funding for states and localities--$100 million over five years--to tangibly assist state public health departments and other local entities to support the development and implementation of evidence-based research, interventions, and treatment with respect to-- [[P…

CREC-2026-07-20-PT1-PGH4640 · READ IN THE CONGRESSIONAL RECORD

The complete record

Every one of 16 lines we hold for Christopher H. Smith, in date order, each linked to its source. Free to read, in full, without an account.

  1. I want to thank others, including my friend Frank Pallone; Doris Matsui, who is the prime Democrat cosponsor; Mr. Bilirakis, one of the originals and a great supporter; Ms. Pingree; Ms. Tenney; Mr. Mfume; and others. We have others, but they were the originals. I also want to thank some of my staff, including Rebecca West, Evan Heitman, John McDonough, who worked overtime--as you know, so many details to be attended to--and, of course, the Staff Director Megan Jackson; Emma Schultheis; and Jackie Weinrich, who worked on the Democrat side in helping to get this to the floor. I thank them all so much. Mr. Speaker, this will save lives, and I urge support for it.

    CREC-2026-07-20-PT1-PGH4642 · READ IN THE CONGRESSIONAL RECORD

  2. Speaker, the program registry allows patients and physicians to locate matching cord blood units, as well as adult a donors, for marrow and peripheral blood stem cells. The program is the world's largest, most diverse donor registry, with more than 43 million potential marrow donors around the world. To date, NMDP, through its operation of the program, has facilitated over 150,000 transplants. The bill before us today, Mr. Speaker, authorizes $280 million for these programs over 5 years--$115 million for cord blood, $165 million for bone marrow programs--to ensure that thousands of present and future patients benefit from this extraordinary field of regenerative medicine. Mr. Speaker, I am deeply grateful to Chairman Guthrie for his amazing support and leadership in advancing the bill.

    CREC-2026-07-20-PT1-PGH4642 · READ IN THE CONGRESSIONAL RECORD

  3. She said there is exciting research now using cord blood to treat children with cerebral palsy, birth asphyxia, and autism. Mr. Speaker, the National Cord Blood Inventory--created by the original law and continued in this reauthorization--provides funding to public cord blood banks participating in the program to allow them to expand the national inventory of cord blood units that are available for transplant. These units are then listed on the registry by the National Marrow Donor Program. The funds appropriated thus far have led to an important increase in the use of these units. The registry now has approximately 121,000 available units. The program registry allows patients and physicians to locate matching cord blood units, as well as adult donors, for both marrow and peripheral blood stem cell transplants. Mr.

    CREC-2026-07-20-PT1-PGH4642 · READ IN THE CONGRESSIONAL RECORD

  4. Joanne Kurtzberg of Duke University, an internationally renowned expert in pediatric hematology, oncology, and umbilical cord blood banking and transplantation. Dr. Kurtzberg helped draft our original law 26 years ago. It took 5 long years to enact it into law. It was blocked at many turns, but she was right there from the beginning and continues to be an extraordinary pioneer in the field. Earlier today, I called Dr. Kurtzberg--we do talk a lot--and she said cord blood has been used as a donor for transplant, enabling over 50,000 patients with cancer, blood disease, and other genetic conditions to have a life-saving treatment. Cord blood is also used as starting material for manufacturing immune effector cells, like CAR T cells, and others to treat patients with cancer and autoimmune diseases.

    CREC-2026-07-20-PT1-PGH4642 · READ IN THE CONGRESSIONAL RECORD

  5. That law created a new nationwide umbilical cord blood stem cell program designed to collect, type, and cryogenically freeze cord blood units for transplantation into patients to mitigate and cure serious disease. The law also provided that cord blood stem cells be used for research. The new cord blood program was combined with an expanded bone marrow initiative, crafted over several years by our distinguished former colleague, Congressman Bill Young. Mr. Speaker, umbilical cord blood stem cells obtained after the birth of a child have proven to be highly efficacious in treating over 75 diseases, including lymphoma, leukemia, sickle cell disease, and other metabolic and immune deficiencies. I thank Dr.

    CREC-2026-07-20-PT1-PGH4642 · READ IN THE CONGRESSIONAL RECORD

  6. Mr. Speaker, each year over 3.6 million babies are born in the United States. In the past, virtually every placenta and umbilical cord was tossed as medical waste. Today, doctors have turned this medical waste into medical miracles. Not only has God, in his infinite wisdom and goodness, created a placenta and an umbilical cord to nurture and protect the precious life of an unborn child, but now we know another gift awaits immediately after birth. Something very special is left behind: umbilical cord blood that is teeming with life-saving stem cells. Mr. Speaker, today the House will vote to reauthorize the Stem Cell Therapeutic and Research Act of 2005, a law that I authored 21 years ago.

    CREC-2026-07-20-PT1-PGH4642 · READ IN THE CONGRESSIONAL RECORD

  7. 4348, as well as his Staff Director Megan Jackson and Health Subcommittee staff Jay Gulshen and Emma Schultheis. Special thanks to Ranking Member Frank Pallone, Health Subcommittee Chair Morgan Griffith and Ranking Member Diana DeGette as well as original cosponsors Lloyd Doggett, Paul Tonko, and Tom Kean.

    CREC-2026-07-20-PT1-PGH4640 · READ IN THE CONGRESSIONAL RECORD

  8. 434--again as we did in the original law--authorizes cooperative agreement funding for states and localities--$100 million over five years--to tangibly assist state public health departments and other local entities to support the development and implementation of evidence-based research, interventions, and treatment with respect to-- [[Page H4642]] educating and informing the public, based on evidence-based public health research and data, about Lyme Disease and other vector-borne diseases; supporting early detection and diagnosis; supporting prevention; improving treatment; and supporting care planning and management for individuals with Lyme disease and other tick- and vector-borne diseases. I thank the Chairman Brett Guthrie for his personal and extraordinarily strong support of H.R.

    CREC-2026-07-20-PT1-PGH4640 · READ IN THE CONGRESSIONAL RECORD

  9. Disseminate and implement public health tools, programs, and collaborations to prevent, detect, diagnose, and respond to VBD threats. H.R. 4348, supports this whole of government assault on Lyme and other vector borne diseases. H.R. 4348 again authorizes $50 million over five years for the regional centers of excellence, which coordinate with academia and local public health agencies to conduct research on Lyme in their areas and train public health professionals to identify and treat Lyme. Finally, H.R.

    CREC-2026-07-20-PT1-PGH4640 · READ IN THE CONGRESSIONAL RECORD

  10. It also, as we did in the original law, authorizes $100 million over 5 years to tangibly assist States' public health departments and other local entities to support the development and implementation of evidence-based research interventions and treatment with respect to the Lyme disease epidemic. I urge my colleagues to support it. Mr. Speaker, in February, 2024, HHS released the National Public Health Strategy to Prevent and Control Vector-borne Diseases in People with mutually reinforcing goals to: Better understand when, where, and how people are exposed to and get sick or die from VBDs. Develop, evaluate, and improve tools, methods, and guidance to diagnose VBDs and their pathogens. Develop, evaluate, and improve tools, methods, and guidance to prevent and control VBDs. Develop and assess drugs and treatment strategies for VBDs.

    CREC-2026-07-20-PT1-PGH4640 · READ IN THE CONGRESSIONAL RECORD

  11. I introduced my first comprehensive bill--one of many, at times we had over 100 cosponsors--called the Lyme Disease Initiative Act of 1998, almost 30 years ago. We could not move it. It was blocked over and over again. There were some people in HHS and at CDC and elsewhere who were saying, just take 2 weeks of doxycycline and you are cured. When you have chronic Lyme, it takes a very serious effort, very often with a Lyme literate doctor, in order to overcome and put that disease into remission. In February 2024, I remind my colleagues, HHS released the National Public Health Strategy to prevent and control vector-borne diseases. It is an excellent strategy. We are acting on that now as well. It also supports the whole-of-government assault on Lyme. It authorizes $50 million over 5 years for Regional Centers of Excellence.

    CREC-2026-07-20-PT1-PGH4640 · READ IN THE CONGRESSIONAL RECORD

  12. The original Kay Hagan Tick Act, which I led in 2019 here in the House and Susan Collins led it in the Senate, became part of the appropriations act in 2020. The act created, among other things, a whole-of-government national strategy to combat Lyme and other tick- borne diseases with special focus on surveillance, diagnosis, treatment, education, and prevention. I would note parenthetically that I have been working on Lyme disease since 1992, when Pat Smith--no relation--of Wall Township, who actually formed the Lyme Disease Association of America, came up to me in Wall Township and said: What are you doing about Lyme? I said: Nothing. We had lunch. I have been working on it ever since.

    CREC-2026-07-20-PT1-PGH4640 · READ IN THE CONGRESSIONAL RECORD

  13. Vector-borne diseases are now endemic in regions of the country where they have not historically been present. Disease-laden ticks are now found in all 48 contiguous States. The problem is exploding. It is not abating. It is, therefore, critical that Congress take immediate action to support and further sustain ongoing efforts to combat these insidious diseases that kill and disable. I urge my colleagues to support H.R. 4348, a 5-year reauthorization of the Kay Hagan Tick Act, a law that expires on September 30th. My colleagues will recall that our distinguished colleague, North Carolina Senator Kay Hagan, suffered a tick bite and died in 2019 from encephalitis caused by the Powassan virus. The current law and reauthorization is named in her honor.

    CREC-2026-07-20-PT1-PGH4640 · READ IN THE CONGRESSIONAL RECORD

  14. More than 476,000 Americans are diagnosed with Lyme disease each year, and recent data show emergency room visits for tick bites reached their highest springtime level in nearly a decade.'' Secretary Kennedy also announced new actions to combat Alpha-gal syndrome, a tick-associated condition that can trigger potentially serious allergic reactions to red meat and other products. The CDC estimates nearly 500,000 Americans are living with Alpha-gal syndrome, though emerging evidence suggests the true number may be significantly higher. Mr. Speaker, as my colleagues know, ticks not only transmit Lyme disease but other deadly and debilitating illnesses, such as Alpha-gal, babesiosis, Powassan disease, Rocky Mountain spotted fever, and anaplasmosis.

    CREC-2026-07-20-PT1-PGH4640 · READ IN THE CONGRESSIONAL RECORD

  15. Today, the Trump administration is launching one of the most ambitious Federal efforts ever to combat Lyme disease by accelerating research, expanding innovation, and improving care for patients and families. We are going after this disease at its source, driving faster diagnostics and new prevention strategies, and delivering the urgency and action Americans deserve.'' He said: ``The initiative will develop and deploy practical strategies to target and eliminate ticks on wildlife before they can spread diseases to humans.'' That has been lacking for decades. They are going after the ticks themselves. ``Lyme disease,'' Mr. Speaker, he said: ``remains one of the Nation's fastest growing vector-borne health threats.

    CREC-2026-07-20-PT1-PGH4640 · READ IN THE CONGRESSIONAL RECORD

  16. Mr. Speaker, I thank Chairman Guthrie for his personal and extraordinarily strong support of H.R. 4348, and his staff, director Megan Jackson, Health Subcommittee staff Jay Gulshen and Emma Schultheis. I also thank my good friend, Frank Pallone, our Health Subcommittee Chair Morgan Griffith, Ranking Member Diana DeGette, as well as the original sponsors, Lloyd Doggett, Paul Tonko, and Tom Kean. Mr. Speaker, at a May 29th press conference in New Hampshire, HHS Secretary Robert F. Kennedy, Jr., who has been a tremendous leader in the war on Lyme disease, announced a ``sweeping plan to combat Lyme disease and to advance treatment.'' Secretary Kennedy said: ``Millions of Americans battling Lyme disease and other tick-borne illnesses have spent years searching for answers, treatment, and support.

    CREC-2026-07-20-PT1-PGH4640 · READ IN THE CONGRESSIONAL RECORD